Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Karienn S. Montgomery"'
Autor:
Eunyoung Bang, Angelika Tobery, Karienn S. Montgomery, Annette S. Fincher, David J. Earnest, David A. Murchison, William H. Griffith
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
The antidepressant drug amitriptyline is used in the treatment of clinical depression and a variety of neurological conditions such as anxiety, neuropathic pain disorders and migraine. Antidepressants are associated with both therapeutic and untoward
Externí odkaz:
https://doaj.org/article/1bde21b058c2430c9b20a85a4c147e6d
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
David Murchison, Angelika N. Tobery, Eunyoung Bang, David J. Earnest, Annette S. Fincher, William H. Griffith, Karienn S. Montgomery
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience
The antidepressant drug amitriptyline is used in the treatment of clinical depression and a variety of neurological conditions such as anxiety, neuropathic pain disorders and migraine. Antidepressants are associated with both therapeutic and untoward
Autor:
Aditya Panta, Farida Sohrabji, Karienn S. Montgomery, Kathiresh Kumar Mani, Marissa Nicolas, Dayalan Sampath
Publikováno v:
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience, Vol 12 (2020)
Frontiers in Aging Neuroscience, Vol 12 (2020)
Cognitive impairment and memory loss are commonly seen after stroke and a third of patients will develop signs of dementia a year after stroke. Despite a large number of studies on the beneficial effects of neuroprotectants, few studies have examined
Autor:
Amal A. Halawa, Daisy Consuegra-Garcia, Katherine A. Rees, Ursula H. Winzer-Serhan, Alexandra M. Tan, Bryan L. Clossen, Victoria M. Golub, D. Samba Reddy, Karienn S. Montgomery, William H. Griffith
Publikováno v:
Brain research. 1746
The human 15q13.3 microdeletion syndrome (DS) is caused by a heterozygous microdeletion (MD) affecting six genes: FAN1; MTMR10; TRPM1; KLF13; OTUD7A; and CHRNA7. Carriers are at risk for intellectual disability, epilepsy, autism spectrum disorder, an
Autor:
Annette S. Fincher, Eric A. Bancroft, Dustin W. DuBois, Vincent Provasek, Ewelina A. Migut, David Murchison, Karienn S. Montgomery
Publikováno v:
Alcohol. 71:75-87
Perinatal ethanol exposure disrupts a variety of developmental processes in neurons important for establishing a healthy brain. These ethanol-induced impairments known as fetal alcohol spectrum disorder (FASD) are not fully understood, and currently,
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
Yona Levites, George A. Edwards, Ashok V. Kumar, Mark A. Gluck, Catherine E. Myers, Jennifer L. Bizon, Barry Setlow, Karienn S. Montgomery
Publikováno v:
Hippocampus. 26:455-471
Elevated β-amyloid and impaired synaptic function in hippocampus are among the earliest manifestations of Alzheimer's disease (AD). Most cognitive assessments employed in both humans and animal models, however, are insensitive to this early disease
Autor:
Karienn S. Montgomery, Dustin W. DuBois, Vincent E. Provasek, William H. Griffith, Eric A Bancroft
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
James W. Grau, B.S. Beas, Sandra M. Garraway, J.R. Huie, Kevin C. Hoy, Jennifer L. Bizon, Kyle M. Baumbauer, Karienn S. Montgomery
Publikováno v:
Neuroscience. 200:74-90
Brain-derived neurotrophic factor (BDNF) has been characterized as a potent modulator of neural plasticity in both the brain and spinal cord. The present experiments use an in vivo model system to demonstrate that training with controllable stimulati